Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346]

Draft guidance: 1

Draft guidance (downloadable version) (PDF 264 KB)

Draft guidance (online commenting)

Committee papers (PDF 7.39 MB)

Public committee slides (PDF 744 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 108 KB)

Final scope (PDF 120 KB)

Equality impact assessment (downloadable version) (PDF 100 KB)

Draft scope post referral (PDF 173 KB)